Medications for Opioid Use Disorder for Youth: Patient, Caregiver, and Clinician Perspectives.

ABSTRACT:

Purpose

Clinical trial data support use of medications for opioid use disorder (MOUD) in adolescents and young adults ("youth"), but qualitative data are lacking on the acceptability and importance of MOUD to youth, caregivers, and clinicians. We assessed how these stakeholders viewed the role of MOUD in treatment and recovery.

Methods

We recruited youth aged from 15 to 25 years with opioid use disorder who had received buprenorphine, naltrexone, or methadone and caregivers from a primary care-based youth addiction treatment program. We also recruited clinicians with addiction expertise from social work, nursing, pediatrics, internal medicine, and psychiatry. We conducted semistructured interviews assessing special considerations for MOUD use in youth. Three coders performed

SUBMITTER: Buchholz C 

PROVIDER: S-EPMC10842045 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature